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Context: Decidualization of the human endometrium, which involves morphological and biochemical 
modifications of the endometrial stromal cells (ESCs), is a prerequisite for adequate trophoblast 
invasion and placenta formation.  
Objective: This study aims to investigate the proteome and secretome of in vitro decidualized ESCs. 
These data were combined with published genomic information and integrated to model the human 
decidualization interactome. 
Design: Prospective experimental case-control study.  
Setting: A private research foundation. 
Patients: Sixteen healthy volunteer ovum donors.  
Intervention: Endometrial samples were obtained, and ESCs were isolated and decidualized in vitro.  
Main Outcome Measures: Two-dimensional difference in-gel electrophoresis, matrix-assisted laser 
desorption/ionization-time-of-flight mass spectrometry, Western blot, Human Protein Cytokine Array, 
ELISA and bioinformatics analysis were performed. 
Results: The proteomic analysis revealed 60 differentially expressed proteins (36 over- and 24 
underexpressed) in decidualized versus control ESCs, including known decidualization markers 
(cathepsin B) and new biomarkers (transglutaminase 2, peroxiredoxin 4 and the ACTB protein). In the 
secretomic analysis, a total of 13 secreted proteins (11 up- and 2 down-regulated) were identified, 
including well recognized markers (IGFBP-1 and PRL) and novel ones (MPIF-1 and PECAM-1). This 
proteome/secretome profiles have been integrated into a decidualization interactome model. 
Conclusions: Proteomic and secretomic have been used as hypothesis-free approaches together with 
complex bioinformatics to model the human decidual interactome for the first time. We confirm previous 
knowledge, describe new molecules and we have build-up a model for human in vitro decidualization as 









Decidualization of human endometrial stromal cells (ESCs) is essential for coordinated 
trophoblast invasion and placenta formation since its defect predisposes to related pregnancy 
complications, including miscarriage, preeclampsia, fetal growth restriction and preterm labor.  
Unlike rodents, the decidual reaction in humans is a conceptus-independent process. It comprises 
morphogenic, biochemical and vascular modifications initiated by the presence of progesterone (P) after 
proper estrogen (E2) priming (1). Morphologically, it is characterized by elongated fibroblast-like ESCs 
transformed into enlarged round cells with specific ultrastructural modifications, accompanied by the 
secretion of specific markers such as prolactin (PRL) and the insulin-like growth factor binding protein-1 
(IGFBP-1) (2), plus extracellular matrices such as laminin, type IV collagen, fibronectin and heparin 
sulphate proteoglycan as part of their differentiation program (3, 4, 5). The onset of this process in the 
ESCs surrounding the terminal spiral arteries marks the end of the window of receptivity, where embryo 
adhesion to the endometrial epithelium can occur.  
The majority of our knowledge of the regulation and mechanisms of human decidualization has 
been generated from in vitro model systems. The exposure of primary ESC cultures to P for 7-9 days, 
alone or in combination with E2, triggers the expression of decidual markers (6, 7, 8). This response is 
mediated by a gradual increase in intracellular cAMP levels and is abrogated in the presence of PKA 
inhibitors. The addition of dibutyryl cAMP (dbcAMP) leads to the in vitro decidualization of ESCs, 
which is used as a non hormonal decidualization stimulus (9, 10).  
Microarray studies of decidualized ESCs have demonstrated a striking deregulation of genes 
associated with the extracellular matrix and tissue integrity, which suggests that these changes are 
prominent features (11, 12). Gene expression is only one dimension of the complex regulatory network 
that allows cells to respond to intracellular and extracellular signals. An initial attempt to use proteomic 
technologies to understand in vitro decidualization was published by Han et al. (13), and was based on 
surface-enhanced laser desertion/ionization time-of-flight mass spectrometry (SELDI-TOF-MS). Six 
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peaks detected by H4 and CM10 ProteinChips were found with a different expression between the non- 
decidual and 8-Br-cAMP-induced decidual cells corresponding to potential protein candidates (13).   
Nevertheless, a comprehensively wide proteomic analysis underlying the mechanisms involved 
in the decidualization process is lacking. In the present study, we performed an in-depth analysis of the 
intracellular and secreted proteins during in vitro ESCs decidualization using a proteomic approach by 
combining gel-based methods and protein arrays. The information obtained has been integrated with the 
available genomic data (14) using state-of-the-art bioinformatic methods, resulting in the modeling of the 















SUBJECTS AND METHODS 
Subjects 
This project received institutional review board approval by the Ethics Committee of IU-IVI 
(Valencia, Spain). Endometrial samples were acquired for research after obtaining a written consent from 
patients. A total of 16 human endometrial biopsies were collected on the day of oocyte retrieval from 
healthy ovum donors aged between 18 and 32. They were obtained with a pipelle catheter (Genetics, 
Belgium) under sterile conditions, processed and the stromal compartment was separated.  
In vitro decidualization was induced by culturing ESCs in media containing progesterone and 
17β-estradiol for 12 days. Decidualization was confirmed morphologically and by IGFBP-1 and PRL 
levels. For the proteomic study, 11 sets of samples (control vs. decidualized cells) were analyzed by 
fluorescence difference in-gel electrophoresis (2D-DIGE) and matrix-assisted laser 
desorption/ionization-mass spectrometry (MALDI-MS) technology. The partial secretomic analysis was 
performed with 7 of these 11 sets of samples using a human protein cytokine array. The number of 
samples analyzed by secretomic was based on the balance between proper n number that assure 
credibility and financial constrains. Validations of the results were performed by Western blot and 
ELISA with 4 sets of samples used in DIGE and the protein arrays analysis, and with the 5 sets outside 
the sample cohort. An extensive bioinformatics analysis was performed to integrate the proteome and 
secretome profiles together with the genomic information present in public databases.  
 
Isolation, culture and decidualization of ESCs 
 
Endometrial biopsies were subjected to mild collagenase digestion as previously described (6). 
ESCs were isolated and grown in 24-well plates using a DMEM/F12 medium containing 10% charcoal-
stripped fetal bovine serum (FBS) and 0.1% antibiotics. After confluence, the medium was replaced with 
fresh media containing 2% FBS and supplemented with 5 ug/mL ascorbic acid and 10 ug/mL transferrin. 
Decidualization in vitro was induced by adding progesterone (1 μmol/L) and 17β-estradiol (30 nmol/L) 
for 12 days. The growth medium with hormones was renewed every 3 days. Control ESCs were cultured 
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in parallel over 12 days without hormonal treatment. The conditioned media from four wells were 
collected and pooled every 3 days, and cells were collected on day 9 of culture. The conditioned media 
was analyzed by ELISA for IGFBP-1 (Raybiotech) and PRL (Abbott Axsym System) levels. 
 
Proteomic analysis  
Proteins were extracted from decidual and control cells directly in lysis buffer (7 M urea, 2M 
thiourea, 4% CHAPS and 30 mM Tris-pH 8.5) containing 50 mM DTT and complete protease inhibitors 
tablets (Boehringuer) using the 2D Grinding Kit (GE Healthcare, Chalfont St Giles, UK). The 
suspension was shaken for 40 min at room temperature and centrifuged at 16000g for 15 min. Interfering 
components were removed using the 2D Clean Up Kit (GE Healthcare), and proteins were resuspended 
in lysis buffer. The protein concentration was determined using the RD/DC Protein Assay (Bio-Rad 
Laboratories, Hercules, CA, USA).  
Proteins were labeled according to the manufacturer’s indications (GE Healthcare). Briefly, 50 
µg of decidual and control protein extracts were minimally labeled with 400 pmol of the Cy3 or Cy5 
fluorescent cyanine dyes on ice in the dark for 30 min. To avoid any possible bias by labeling efficiency, 
we labeled half the samples from each group with Cy3 dye and the other half with the Cy5 dye. An 
internal standard, containing equal amounts of each cell lysate, was labeled with the fluorescent Cy2 dye 
and used for all the experiments. The labeling reaction was quenched with 1 µl of 10 mM lysine on ice 
for 10 min in the dark. The decidual and control protein extracts, and the internal standard protein 
samples, were combined and run in a single gel (150 µg total proteins). Protein extracts were applied by 
rehydration in immobilized pH gradient (IPG) strips (24 cm, pH 3-11, nonlinear) and subjected to 
isoelectrofocusing in an IPGphor Isoelectric Focusing System II (GE Healthcare) according to the 
manufacturer´s recommendations. After the first dimension, strips were equilibrated in SDS equilibration 
buffer (75 mM Tris pH 8.8, 6 M urea, 30% (v/v) glycerol, 2% (w/v) sodium dodecyl sulfate (SDS), 
traces of bromophenol blue) containing 1% (w/v) DTT for 15 min, and thereafter in SDS equilibration 
buffer containing 4% (w/v) iodoacetamide for another 15 min. Then proteins were separated on 10-
12.5% SDS-PAGE gels using an Ettan Dalt Six device (GE Healthcare) at 25ºC until the tracking dye 
had migrated off the bottom of the gel. 
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Fluorescence images of the gels were acquired on a Typhoon 9400 scanner (GE Healthcare) and 
relative protein quantification was performed using the DeCyder software, v 7.0 (GE Healthcare), as 
previously described (15).  
These spots were manually excised from the silver-stained gels and digested with trypsin in 
accordance with the protocol of Shevchenko et al. (16), save minor modifications. Briefly, MALDI 
samples were prepared and automatically analyzed in an Ultraflex MALDI-TOF/TOF mass spectrometer 
(Bruker Daltonik) (17) with an automated analysis loop using internal mass calibration, controlled by the 
flexControl 2.2 software (Bruker Daltonik). MALDI-MS spectra were acquired by averaging 300 
individual spectra in the positive ion reflector mode at 50 Hz laser frequency in a mass range from 800 to 
4000 Da. An internal calibration of the MALDI-MS mass spectra was performed using two trypsin 
autolysis ions with m/z ¼ 842.510 and m/z ¼ 2211.105. The precursor ions with a signal-to-noise ratio 
of ≥20 in the MALDI -MS mass spectrum were submitted to a fragment ion analysis in the tandem 
(MS/MS) mode. The MALDI-MS and MS/MS data were combined through the BioTools 3.0 program 
(Bruker Daltonik) to search a nonredundant protein database (NCBInr; ~6.5 x 106 entries, National 
Center for Biotechnology Information, Bethesda US) using the Mascot 2.2.1 software (Matrix Science, 
London, UK) (18). Protein scores over 80 were considered significant (P < 0.05). 
 
Western blot 
Proteins (80 µg) from the decidual and control cells were separated by discontinuous 
electrophoresis (stacking gel 4% polyacrylamide and resolving gel 12% polyacrylamide) for 1 h at 180 
V. Later, proteins were transferred onto the polyvinylidene fluoride (PVDF) membrane by wet 
electroblotting using the tris/glycine transfer buffer (Biorad) for 4 h at 4ºC with shaking. PVDF 
membranes were blocked in PBS and 5% dry non-fat milk at room temperature for 1 h. Immunoblotting 
was performed with primary antibodies; 2.5 μg /ml mouse monoclonal transgelin, 2 μg/ml mouse 
monoclonal alpha actinin, 2 μg /ml mouse monoclonal transglutaminase 2 and 0.25 μg/ml mouse 
monoclonal cathepsin B (all of Abcam, Cambridge, UK) at 4ºC. Then membranes were incubated with 
the 1:2000 dilution of the polyclonal goat anti-rabbit IgG-HRP (DakoCytomation, CA) and the 
polyclonal rabbit anti-goat IgG-HRP (DakoCytomation, CA) at room temperature for 1 h. PVDF 
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membranes were analyzed with the ECL Western Blotting Analysis System (GE Healthcare, Freiburg, 
Germany) and were photographed using Fujifilm LAS-300. The subsequent densitometry analysis of 
bands was done with the Fujifilm Multi Gauge V3.0 program. Membranes were stripped and incubated 
with a monoclonal mouse antihuman 0.4 mg/ml GAPDH antibody (Abcam, Cambridge, UK) and 
processed as above. 
 
Secretomic analysis 
The conditioned media obtained from 7 sets of decidual and control cells collected on day 9 were 
compared using the Human Cytokine Antibody Array G Series 2000 (Raybiotech). Arrays contained 174 
human cytokines which could be simultaneously compared in a single experiment between two given 
conditions (19, 20). Antibody array slides were blocked for 30 min at room temperature prior to media 
incubation. Briefly, the decidual and control conditioned media (100 µL each) and the media without 
cells (DMEN/F12 with 2% SBF) (100 µL) were incubated in three different membranes (arrays VI, VII 
and VIII) for 2 h at room temperature. After sample incubation and washing, a diluted biotin-conjugated 
anti-cytokine primary antibody was applied to each membrane for 2 h at room temperature. After 
washing, diluted fluorescent dye-conjugated streptavidin was added to the membranes for 2 h at room 
temperature in the dark. Slides were washed and water droplets were removed by centrifuging at 1000 
rpm for 3 min. Then slides were left to dry completely in air for at least 20 min. Arrays were scanned in 
an Axon 4100A scanner (Molecular Devices, Sunnyvale, CA, USA) and data were extracted with the 
GenePix Pro 6.0 software (Molecular Devices). 
The GenePix Pro 6.0 software was used for the array image analysis and to calculate spot 
intensity measurements which were considered raw data. Spot intensities (medians) with background 
subtraction were transformed to the log2 scale. Before quantile normalization, data were represented in a 
box plot to know the data distribution and subtract abnormal microarray data. Replicates per protein 
symbol were merged. 
The R-statistical software system was used as a tool for these purposes and the downstream 
analysis. The protein expression profile was determined by comparing decidual and control conditioned 
media with parametric and nonparametric tests, and two criteria were used to define those proteins with 
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altered abundance among the different sample sets: an absolute fold change of 1.5 or more, and a 
corresponding p-value lower than 0.05. 
 
ELISA analysis 
The conditioned media from both decidual and control cells were evaluated in duplicate using the 
commercial ELISA kit for MPIF-1, IL-6 and MCP-3 (Raybiotech) and IL1R-II (Hycult biotech). Sample 
values (pg/mL) were determined using the standard curve.  
 
Statistical analysis 
ELISA analysis data and levels of prolactin and IGFBP-1 secretions were processed for statistical 
evaluation. Quantitative data are presented as mean ± SD. A nonparametric Mann-Whitney U-test was 
done to compare the average ratios for each molecule (ng/mL) between decidual and control samples. 
Statistical significance was defined as a P-value of <0.05.  
 
Bioinformatics analysis of the results 
 A bioinformatics analysis pipeline was developed to integrate the proteome and secretome 
profiles together with the information present in public databases and data repositories. 
 An interaction network between those proteins, detected as being differentially regulated both 
intra- and extracellularly, was created using the Snow application (http://snow.bioinfo.cipf.es) (21) 
present in the functional analysis suite, Babelomics (http://www.babelomics.org) (22). Although the 
progesterone and estradiol receptors (PGR, ESR1 and ESR2) were not detected as being differentially 
expressed, they were also included in the set of interacting proteins as they represent the primary 
entrance for the hormonal signals that trigger decidualization. To construct the interaction network, the 
curated human interaction database available at Snow was used, which includes the physical protein-
protein interactions detected by at least two different experimental methods, and the incorporation of one 
connecting protein (not present in the experimental data) was allowed. This decidualization interactome 
defined as the network of proteins identified from the interaction between proteome and 
secretome, was further completed by including the information available on the transcription factors 
 
 10 
(TFs) regulating the expression of the coding genes for all the proteins in the network. Transcription 
factor data were obtained from the Jaspar database (23), which is included in Babelomics. Additionally, 
the gene expression information of the decidualization process (14) was collected and crossed with the 
proteomic data to identify the gene whose differential expression was observed at both the gene 
expression and protein levels. All the proteins in the resulting network were manually reviewed and 
classified into 19 different functional categories that best described the diversity of the functions in our 





















RESULTS and DISCUSSION 
After 9 days of culture, bona fide in vitro decidualized ESCs were identified by the appearance 
of a rounded decidual phenotype (Fig. 1A&1B) with a significant increase of IGFBP-1 
(98.38±48.07ng/ml) and PRL (60.27±23.71ng/ml) (Fig. 1C&1D). Only those decidualized vs. control 
ESCs pairs (n=16) with a significant increase (P<0.005) in PRL and IGFBP-1 were used for further 
analyses.  
Proteomic analysis of decidualized ESC and validation by Western blot 
Over 2,500 spots were detected across the pI range (3-11 NL) with the DIA module 
(DeCyderTM). The differentially expressed proteins were excised and identified by MALDI peptide mass 
fingerprinting and/or peptide fragmentation using the Mascot search engine (Fig. 2A). A list of 60 
proteins was identified with significantly different abundance between decidualized and controls ESCs: 
36 up- and 24 were down-regulated (Table 1). Among the identified spots, proteins related with the 
cytoskeleton (alpha-actinin, gelsolin and keratin 7), redox homeostasis (superoxide dismutase and 
peroxiredoxin 4), metabolism (triosephosphate isomerase 1 and monoglyceride lipase), and protein 
folding/degradation (cathepsin B and protein disulfide isomerase) were found. In some cases, the same 
protein was identified in two different spots (e.g., caldesmon spots 13 and 14), suggesting the occurrence 
of posttranslational modifications. In addition, two different co-migrating proteins were identified in one 
spot (e.g., spot 2, proteins disulfide-isomerase and ribonuclease inhibitor). 
For validation purposes, transgelin and actinin alpha 1, as significantly underexpressed and 
cathepsin B and transglutaminase 2 as significantly overexpressed, were analyzed by Western blot in 4 
sets of the decidualized vs. control ESCs used in the DIGE analysis. The results obtained demonstrate a 
similar regulation which was reported in the proteomic analysis. Cathepsin B and transglutaminase were 
up-regulated (fold change 1.4 and 1.7, respectively). In contrast, alpha actinin and transgelin 
significantly reduced in the decidualized vs. control cells (fold change -4.5 and -6.1, respectively) (Fig. 
2B). Four additional sets of decidualized and control cells (n=4) outside the initial DIGE cohort were 
analyzed to extend the results to the general population. The results matched those previously reported 
(Fig. 2C).  
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Secretomic analysis of decidualized ESCs and validation by ELISA   
 
The decidual and control-conditioned media (n=7) collected on day 9 of culture were 
comparatively analyzed using a protein array (Supplementary Fig. 1). Table 2 presents the differentially 
secreted proteins; the fold-change and the raw p-values are also shown. As expected, proteins such as 
IGFBP-1 and prolactin significantly increased (raw p < 0.05) in the decidual media. It is noteworthy that 
novel secreted decidualization markers such as MPIF-1, IL-10 beta receptor, IL-21 receptor, PECAM-1, 
the decoy receptor IL-1R II, CD80, leptin receptor also increased (> 2-fold change, raw p < 0.05). Only 
two proteins, IL-6 and MCP-3, significantly reduced in the decidual versus the control media (raw p < 
0.05).  
ELISA validation was performed for two overexpressed (PECAM, MPIF-1) and two 
underexpressed (IL-6 and MCP-3) secreted proteins. ELISA experiment was performed in 4 sets of 
decidualized vs. control-conditioned media collected on day 9, which had already been used in the 
secretome study, thus demonstrating a similar regulation to the array experiment (Fig. 3A). As expected, 
MPIF-1 and ILR1-RI were significantly up-regulated and MCP-3 and IL-6 significantly reduced in the 
decidualized compared to the ESC control media. We also analyzed the 5 additional ESC decidualized 
vs. control-conditioned media obtained outside the array cohort, thus corroborating the results reported 
by the array (Fig. 3B). The results were evaluated with a Mann-Whitney U-test and demonstrate 
statistically significant differences.   
 
Modeling the decidualization interactome 
 
 A total of 47 and 18 unique intracellular and extracellular proteins, respectively, were identified 
as being differentially expressed by our proteomic analysis. Of these 65 proteins, 44 were joined by the 
Snow software into a highly interconnected network where one additional protein between each protein 
pair was allowed. This network contained a total of 132 proteins (44 native and 88 added by the Snow 
software) and 378 interactions (Fig. 4) (Supplementary Table I). A total of 33 transcriptor factors (TFs) 
were found to regulate the expression of the 65 proteins and were also included in the net. Interestingly, 
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5 of these TFs (GATA2, GATA3, SOX10, SPIB, TFAP2A) were classified as “specifiers” by the 
Fantom database (25), which implies that these TFs are expressed in a tissue-specific fashion, where 6 
TFs (USF1, ARID3A, ETS1, BRCA1, NFIC, YY1) were “facilitators”, or broadly expressed regulators. 
By crossing the proteomic data with the set of 734 differentially expressed genes with our proteomic 
data, were identified 15 genes differentially expressed at both mRNA expression and protein level. 
These genes include native proteins (Caldesmon 1, actinin alpha 4, transgelin, calponin), transcription 
factors (NR4A, BRCA1) and additional nodes (IGFBP1, laminin A/C, vimentin, vinculin, cyclin-
dependent kinase 1, serpin peptidase inhibitor E).  
Functional annotation of the identified decidualization components reveals a number of 
interesting aspects in the biology of this process. First, a large proportion of the intracellular regulated 
proteins related to cytoskeleton organization, extracellular matrix composition and the connection 
between the two cellular architectural complexes. Initiation of decidualization was accompanied by a 
significant up-regulation of actin (beta and gamma actins), while a disruption of the actin filaments 
altered the decidualization course (26). It has been recently demonstrated that destabilization of the 
cytoskeleton accelerates decidualization, whereas increased phosphorylation of the myosin light chain 
prevents decidualization (27). Given the importance of cytoskeletal restructuring during decidualization, 
it is not altogether surprising that 28% of the proteins found actually relate to the cytoskeleton and are 
regulated during decidualization. Transgelin, also known as smooth muscle protein 22 (SM22) (28), has 
not been described before in human decidualization and is, therefore, a novel intracellular biomarker.  
Second, substantial modifications in the extracellular matrix were reflected by a down-regulation 
of metalloproteases (MMP2, MMP3 and MMP14), with an increase in protease inhibitors such as 
TIMP1. Their balance is fundamental for the controlled invasion of trophoblast by decidual cells.  
Steroid hormones (E and P) play a pivotal role and their receptors PGR, ESR1 and ESR2 have 
been incorporated into the decidualization interactome to analyze relations with significant proteins. The 
appropriate functioning of steroid hormone receptors depends on their interaction with molecular 
chaperones such as chaperonin containing TCP1, protein disulfide isomerise, and heat shock protein 27 
which, interestingly, up-regulated in decidualized ESCs.  
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Decidual cells are a source of growth factors and cytokines that support/control trophoblast invasion 
(29, 30).  A total of 13 differentially secreted proteins were found (11 up- and 2 down-regulated). 
Among the most regulated well recognized markers, IGFBP-1 (6.51-fold increase) and PRL (2.44-fold 
increase) were present, along with a novel one, MPIF-1 (7.02-fold increase). This molecule also known 
as CCL23, shows chemotactic activity for monocytes, resting T-lymphocytes and neutrophils, but not for 
activated lymphocytes. This chemokine participates in cell-cell signaling, chemotaxis, immune and 
inflammatory responses (31). Human MPIF-1 induces endothelial cell migration and tube formation in a 
three-dimensional matrigel (3D) via CCR1 receptor binding (32). Neutralization with the anti-MPIF1 
and anti-CCR1 antibodies resulted in a blockage of the MPIF1-activated invasion of HUVECs. These 
results indicate that MPIF-1 may play a direct role in angiogenesis.  
IL-6 and MCP-3 were significantly down-regulated compared to the non decidualized hESCs. 
Exogenous IL-6 has a stimulatory effect on first trimester cytotrophoblast invasion, and anti-IL-6 
inhibited this effect (33). MCP-3, also known as CCL7, is a chemotactic factor that binds to different 
receptors CCR1, CCR2 and CCR3. Migration assays have employed the trophoblast cell line that most 
closely resembles the extravillous cytotrophoblast (AC1M-88), showing that trophoblast migration does 
not occur in response to CCL7 (34).  
In conclusion, proteomic and secretomic approaches integrated with genetic background, have 
been employed in this work using complex bioinformatics to model the human decidual interactome for 
the first time. The results reveal that the implicated proteins are included in different categories, mainly 
relating to actin cytoskeleton regulation, cell adhesion, protein folding and degradation, redox 
homeostasis and signal transduction. We present this model as a tool for the diagnosis, therapy and 
interpretation of biological phenomena in health and disease models such as preeclampsia or 
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FIGURES AND TABLES 
 
 
Figure 1.  In vitro decidualization. 
(A) Morphology of human ESCs cultured without hormonal treatment for 9 days. (B) Decidualized 
human ESCs cultured with progesterone and 17β-estradiol for 9 days. (C&D) Prolactin & IGFBP-1 
secretions measured by ELISA presented as ng/mL (mean+ SD) in control (white bar) and decidualized 
(black bar) cultures on days 0, 3, 6, 9 and 12 of culture.  * p-value < 0.05 **p-value< 0.005. 
 
Figure 2. 2D-DIGE of decidualized (D) vs. control (C) ESCs and validation.  
Individual proteins of control cells, decidual cells and a pooled internal standard were labeled with 
CyDyes, Cy3, Cy5 and Cy2 respectively, and were mixed and separated on a 2D gel using 24 cm pH 3-
11 NL (left to right) strips in the first dimension and 10% PAGE-SDS gels in the second dimension. Gels 
were scanned to obtain images of the overlay of the two dyes (Cy3, Cy5) (A.1, A.2). The same gels, after 
fluorescence imaging, were silver-stained and scanned (A.3, A.4). The 53 protein spots found to be 
significantly deregulated in the decidualizated vs. the control samples (P< 0.05) are encircled. The 
proteins identified by in-gel trypsin digestion and MALDI-TOF/TOF are summarized in Table I. 
Validation of the DIGE experiments of alpha-actinin, transgelin, cathepsinB and transglutaminase by 
Western blot. (B)  Protein extracts from endometrial samples used in the DIGE experiments; bands 
correspond to 107 kDa alpha actinin and 23 kDa transgelin. Both significantly reduced in the 
decidualized versus the control cells (densitometry values of -4.5 and -6.1, respectively); 38 kDa 
cathepsin B and 90 kDa transglutaminase proteins were found up-regulated (densitometry values of 1.4 
and 1.7, respectively) (C) validation experiments were also performed in a new set of samples which had 
not been previously analyzed in the DIGE cohort. The results matched the previous ones. GAPDH was 
used as a control to normalize protein abundance in all the experiments performed. The densitometric 




Figure 3. Secretome profile validation of MPIF-1, IL1 RII, MCP-3 and IL-6 measured by ELISA in the 
conditioned media from the decidual (D) and control (C) ESCs.  
(A) MPIF, IL1 RII, MCP-3 and IL-6 were analyzed in 4 experiments using conditioned media which had 
been already investigated in the secretome analysis.  
(B) To validate the biological significance outside the sample cohort, 6 additional sets of control and 
decidual samples were used. 
The results in pg/ml are shown as mean ±SD of the control- (white bar) vs. the decidual- (black bar) 
conditioned media for each molecule.  
* p-value < 0.05, ** p-value < 0.01  
 
Figure 4. Decidualization Interactome including the proteins detected in our study as differentially 
regulated, both intra- and extracellularly together with the information present in public databases and 
data repositories.  
(Triangle) The significantly overexpressed proteins in our proteomic analysis, (Squaring) The 
significantly underexpressed proteins in our proteomic analysis, (Circle) Transcription factors, 
(Rhombus) Connecting proteins added to construct the interaction network.  
(Pink Line) Direct interactions among the deregulated proteins found in our proteomic analysis. (Blue 
Line) Indirect interactions among the deregulated proteins through connecting proteins. (White Line) 
Interactions among the proteins and transcription factors. (Red Line) Interactions among all the proteins 
and PGR, ESR1 and ESR2. 
Proteins are classified into 15 different functional categories, indicated by different colours in the legend 
(cytoskeleton, redox, exocytosis/endocytosis, cell adhesion/collagen/ECM, protein folding, protein 
degradation, DNA/RNA metabolism, lipid metabolism, heat shock protein, glycolisis, mitochondria, 
extracellular, signal transduction, cell cycle, angiogenesis).  
The remarked proteins correspond to the identified gene whose differential expression was observed at 




Table 1. Proteins identified by MALDI-TOF/TOF showing significant changes between the decidual 
and the control ESCs on day 9 of culture.  
a Spot number as shown in the 2-DE silver gel in Fig. 2 (spots 1-53). bAverage volume ratio 
(decidual/control) as calculated by the DeCyder BVA analysis. cStudent t-test P-value. dProtein accession 
code from the SwissProt database. eMascot score, fExpected value, gTheoretical molecular weight (Da), 
hpI. iNumber of matched peptides and jprotein sequence coverage for the most probable candidate as 
provided by Mascot. Bold represent proteins validated by western blot analysis. 
 
Table 2. List of the secreted proteins modified by the decidualization effect.  
a Protein name as shown in the protein array. bFold change (decidual/control). cStatistical test P-value. 
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Spot DeCyder Accession Gene Protein   Mascot MW pI Matched Cover. 
Number Av Ratio  p (t-test) code name description score expect /Da, theor. theor. peptides % 
  Decid/crtl                    
1 2,35 6,3E-04 gi|39777597 TGM2 transglutaminase 2 isoform a  228 1,4E-16 78420 5,11 6 13 
2 1,97 4,6E-02 gi|119610097 P4HB protein disulfide-isomerase 154 3,5E-09 21410 4,47 4 20 
 1,97 4,6E-02 gi|15029922 RNH1 Ribonuclease inhibitor 154 3,5E-09 50104 4,83 4 12 
3 -1,78 1,1E-02 gi|28723 ACTN1 alpha-actinin  137 1,8E-07 69061 5,07 8 15 
4 3,37 1,1E-02 gi|741376 CTSB cathepsin B 120 8,8E-06 17428 5,44 1 11 
5 -1,99 4,9E-02 gi|67782365 KRT7 keratin 7  179 1,1E-11 51411 5,40 7 18 
6 1,84 9,2E-04 gi|39777597 TGM2 transglutaminase 2 isoform a  111 7,0E-05 78420 5,11 4 8 
7 1,82 1,6E-02 gi|5453790 NNMT nicotinamide N-methyltransferase  159 1,1E-09 30011 5,56 4 17 
8 2,08 1,9E-03 gi|4185720 UCHL1 ubiquitin carboxy-terminal hydrolase L1  183 4,4E-12 23354 5,30 4 25 
 2,08 1,9E-03 gi|39777597 TGM2 transglutaminase 2 isoform a  148 1,4E-08 78420 5,11 6 9 
 2,08 1,9E-03 gi|4185720 UCHL1 ubiquitin carboxy-terminal hydrolase L1  187 1,8E-12 23354 5,3 5 27 
9 2,22 4,9E-02 gi|15277503 ACTB beta actin 170 2,2E-12 40536 5,55 4 15 
10 2,02 1,3E-02 gi|178045 ACTG1 gamma-actin 133 1,1E-08 26147 5,65 3 16 
11 -1,88 3,8E-02 gi|188619 MMP3 matrix metalloproteinase-3 204 3,5E-14 54229 5,61 4 8 
12 1,60 5,8E-03 gi|5453549 PRDX4 peroxiredoxin 4  187 1,8E-12 30749 5,86 5 24 
13 -2,34 4,3E-02 gi|15149465 CALD1 caldesmon 1 isoform 5  225 7,0E-18 61233 6,40 9 23 
14 -2,45 1,6E-02 gi|179830 CALD1 caldesmon 247 1,8E-18 62715 6,18 5 15 
15 -1,56 4,1E-02 gi|3820535 TXNRD1 thioredoxin reductase GRIM-12  295 2,8E-23 55321 6,36 8 20 
 -1,56 4,1E-02 gi|38044288 GSN gelsolin isoform b  109 2,8E-06 80876 5,58 4 5 
16 -1,82 3,1E-02 gi|4502101 ANXA1 annexin I  83 1,1E-03 38918 6,57 6 28 
 -1,82 3,1E-02 gi|5453710 LASP1 LIM and SH3 protein 1  140 2,2E-09 30097 6,61 7 29 
 -1,82 3,1E-02 gi|5668560 PPP1CC serine/threonine phosphatase 1 gamma  83 1,1E-03 34493 5,09 6 16 
17 2,01 6,1E-03 gi|67782309 SOD2 superoxide dismutase [Mn], mitochondrial 138 3,5E-09 20882 8,36 3 17 
18 1,50 4,6E-02 gi|181969 EEF2 elongation factor 2 93 1,2E-04 40264 5,81 1 3 
20 2,17 9,5E-03 gi|67782309 SOD2 superoxide dismutase [Mn], mitochondrial 260 2,2E-21 22290 6,86 6 34 
21 2,04 6,8E-03 gi|32454741 SERPINH1 serpin H1 94 7,9E-05 46525 8,75 1 2 
22 -1,55 2,0E-02 gi|55960374 TAGLN2 transgelin 2  235 2,8E-17 21244 7,63 8 42 
23 -1,56 5,0E-02 gi|75516490 HNRPA1 heterogeneous nuclear ribonucleoprotein A1 144 8,9E-10 16806 9,71 3 27 
24 1,70 2,3E-02 gi|226007 MYL1 ventricular myosin L1 91 1,9E-04 22123 4,97 1 6 
25 1,78 3,0E-02 gi|39777597 TGM2 transglutaminase 2 isoform a  289 2,9E-24 78420 5,11 11 22 
26 -1,52 3,6E-03 gi|5031877 LMNB1 lamin B1  100 2,5E-05 66653 5,11 3 7 
27 1,75 2,1E-02 gi|62087548 LCP1 L-plastin variant  129 2,9E-08 56196 5,21 1 3 
28 1,57 2,0E-02 gi|741376 CTSB cathepsin B 192 1,4E-14 28595 5,23 7 25 
29 -1,43 8,7E-03 gi|938026 RANBP1 Ran-binding protein 1  92 1,6E-04 23396 5,19 1 6 









31 1,76 4,0E-02 gi|741376 CTSB cathepsin B 173 1,1E-12 28595 5,23 4 20 
 1,76 4,0E-02 gi|119620391 CCTB chaperonin containing TCP1, subunit 4 (CRA_b) 121 1,8E-07 28595 5,23 5 12 
32 -1,45 4,3E-02 gi|4501891 ACTN1 actinin, alpha 1 isoform b  387 4,5E-34 1E+05 5,25 25 40 
 -1,45 4,3E-02 gi|12025678 ACTN4 actinin, alpha 4  166 5,7E-12 1E+05 5,27 14 22 
33 -1,40 2,9E-03 gi|1617118 PRDX2 Peroxiredoxin-2 139 2,9E-09 18486 5,19 3 21 
34 1,89 3,2E-02 gi|662841 HSP27 heat shock protein 27  228 3,6E-18 22427 7,83 7 37 
35 -1,51 1,6E-02 gi|5453990 PSME1 proteasome activator subunit 1 isoform 1  135 7,2E-09 28876 5,78 8 29 
36 -1,42 2,3E-02 gi|35068 NME1 Nucleoside diphosphate kinase A 147 4,5E-10 20740 7,07 4 26 
37 -1,81 4,5E-03 gi|116805340 GARS glycyl-tRNA synthetase  139 2,9E-09 83854 6,61 4 5 
38 1,85 4,3E-02 gi|662841 HSP27 heat shock protein 27  157 4,5E-11 22427 7,83 5 33 
39 3,97 3,6E-02 gi|37181873 C1QTNF6 Complement C1q TNF-related protein 6 144 9,1E-10 29093 5,81 3 13 
40 1,57 1,5E-02 gi|17389815 TPI1 Triosephosphate isomerase 1  179 2,9E-13 26910 6,45 5 28 
41 2,22 2,2E-02 gi|21361176 ALDH1A1 aldehyde dehydrogenase 1A1  244 9,1E-20 55454 6,30 6 16 
42 1,74 2,0E-02 gi|61656609 TRAP1 TNF receptor-associated protein 1  123 5,2E-06 57426 7,21 4 9 
43 2,08 2,0E-02 gi|37747855 TF transferrin  98 4,0E-05 79310 6,97 6 11 
44 -2,48 2,5E-02 gi|48255905 TAGLN transgelin  244 9,1E-20 22653 8,87 9 50 
45 2,83 5,3E-04 gi|38202207 MAOB monoamine oxidase B  170 2,3E-12 59238 7,20 7 16 
46 -1,63 9,9E-03 gi|4758018 CNN2 calponin 2 isoform a  116 5,8E-07 34074 6,95 2 8 
47 1,55 2,1E-02 gi|51242953 MGLL monoglyceride lipase isoform 2  149 1,3E-08 33468 6,49 4 16 
48 1,97 2,1E-02 gi|67782309 SOD2 superoxide dismutase 2, mitochondrial isoform B 178 1,6E-11 20882 8,36 5 30 
49 1,47 2,4E-02 gi|55664661 VDAC2 voltage-dependent anion channel 2  220 2,3E-17 30842 8,00 6 26 
50 1,55 2,7E-03 gi|115430223 LGALS3 galectin 3  258 3,6E-21 26193 8,57 9 35 
51 1,40 1,8E-02 gi|595267 HADHA Gastrin-binding protein  106 5,7E-06 83730 9,13 2 3 
52 -2,22 4,3E-02 gi|48255905 TAGLN transgelin  298 3,6E-25 22653 8,87 13 65 









Changeb p-value(%)c Descriptiond 
MPIF-1 7,02 0.001 C-C motif chemokine 23 
IGFBP-1 6,51 0.001 Insulin-like growth factor-binding protein 1 
IL-10_R_beta 4,98 0.005 Interleukin-10 receptor subunit beta 
IL-21R 4,49 0.0002 Interleukin-21 receptor 
PECAM-1 4,20 0.0014 Platelet endotelial cell adhesión molecule 1 
IL-1_R_II 3,39 0.001 Interleukin-1 receptor II 
B7-1(CD80) 2,93 0.002 Activation B7-1 antigen 
Leptin_R 2,74 0.001 Leptin receptor  
IL-5_R_alpha 2,73 0.0001 Interleukin-5 receptor alpha 
PRL 2,44 0.0004 Prolactin 
IL-1_R4/ST2 2,39 0.002 Interleukin-1 receptor 4 
IL-13_R_alpha_2 1,85 0.00 Interleukin-13 receptor alpha 2 
Fas_Ligand 1,81 0.00 Tumor necrosis factor ligand superfamily member 6 
L-Selectin 1,80 0.002 Leukocyte-endothelial cell adhesión molecule 1 
IL-18_BP_alpha 1,64 0.00 Interleukin-18 bind protein alpha 
ICAM-2 1,40 0.003 Intercellular adhesión molecule 2 
IL-6 -2,31 0.00 Interleukin 6 
MCP-3 -3,17 0.001 Chemokine ligand 7 
TABLE 2 
